Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
VRNT vs NICE vs SPOK vs TTEC vs CXM
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Medical - Healthcare Information Services
Information Technology Services
Software - Application
VRNT vs NICE vs SPOK vs TTEC vs CXM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Application | Medical - Healthcare Information Services | Information Technology Services | Software - Application |
| Market Cap | $1.24B | $5.78B | $225M | $149M | $1.34B |
| Revenue (TTM) | $894M | $2.95B | $103M | $2.10B | $857M |
| Net Income (TTM) | $61M | $612M | $11M | $-201M | $23M |
| Gross Margin | 69.9% | 66.4% | 91.4% | 15.5% | 67.4% |
| Operating Margin | 8.6% | 21.9% | 13.2% | 4.3% | 4.7% |
| Forward P/E | 7.0x | 8.7x | 16.4x | 2.5x | 12.0x |
| Total Debt | $448M | $164M | $7M | $1.00B | $47M |
| Cash & Equiv. | $216M | $379M | $25M | $83M | $163M |
VRNT vs NICE vs SPOK vs TTEC vs CXM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | Nov 25 | Return |
|---|---|---|---|
| Verint Systems Inc. (VRNT) | 100 | 45.5 | -54.5% |
| NICE Ltd. (NICE) | 100 | 55.2 | -44.8% |
| Spok Holdings, Inc. (SPOK) | 100 | 148.5 | +48.5% |
| TTEC Holdings, Inc. (TTEC) | 100 | 3.4 | -96.6% |
| Sprinklr, Inc. (CXM) | 100 | 37.5 | -62.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRNT vs NICE vs SPOK vs TTEC vs CXM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRNT ranks third and is worth considering specifically for momentum.
- +17.9% vs NICE's -40.4%
NICE carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 7.7%, EPS growth 43.0%, 3Y rev CAGR 10.5%
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- PEG 0.33 vs VRNT's 0.36
- 7.7% revenue growth vs TTEC's -3.2%
SPOK is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 5 yrs, beta 0.42, yield 11.9%
- 13.3% 10Y total return vs NICE's 50.7%
- Beta 0.42, yield 11.9%, current ratio 1.18x
- Beta 0.42 vs TTEC's 1.84, lower leverage
TTEC is the clearest fit if your priority is value.
- Lower P/E (2.5x vs 12.0x)
Among these 5 stocks, CXM doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.7% revenue growth vs TTEC's -3.2% | |
| Value | Lower P/E (2.5x vs 12.0x) | |
| Quality / Margins | 20.8% margin vs TTEC's -9.6% | |
| Stability / Safety | Beta 0.42 vs TTEC's 1.84, lower leverage | |
| Dividends | 11.9% yield, 5-year raise streak, vs VRNT's 1.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +17.9% vs NICE's -40.4% | |
| Efficiency (ROA) | 11.8% ROA vs TTEC's -14.2%, ROIC 13.2% vs 6.2% |
VRNT vs NICE vs SPOK vs TTEC vs CXM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRNT vs NICE vs SPOK vs TTEC vs CXM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 2 of 6 categories
SPOK leads 2 • TTEC leads 1 • VRNT leads 0 • CXM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NICE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $2.9B annually — 28.5x SPOK's $103M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to TTEC's -9.6%. On growth, NICE holds the edge at +9.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $894M | $2.9B | $103M | $2.1B | $857M |
| EBITDAEarnings before interest/tax | $127M | $845M | $17M | $178M | $48M |
| Net IncomeAfter-tax profit | $61M | $612M | $11M | -$201M | $23M |
| Free Cash FlowCash after capex | $118M | $665M | $26M | $34M | $155M |
| Gross MarginGross profit ÷ Revenue | +69.9% | +66.4% | +91.4% | +15.5% | +67.4% |
| Operating MarginEBIT ÷ Revenue | +8.6% | +21.9% | +13.2% | +4.3% | +4.7% |
| Net MarginNet income ÷ Revenue | +6.9% | +20.8% | +10.3% | -9.6% | +2.7% |
| FCF MarginFCF ÷ Revenue | +13.2% | +22.6% | +24.7% | +1.6% | +18.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.0% | +9.0% | -100.0% | -7.1% | +8.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.1% | +56.5% | -64.0% | -6.6% | -90.1% |
Valuation Metrics
TTEC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 84% valuation discount to CXM's 60.6x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.37x vs VRNT's 1.02x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.2B | $5.8B | $225M | $149M | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $5.6B | $206M | $1.1B | $1.2B |
| Trailing P/EPrice ÷ TTM EPS | 19.72x | 9.89x | 14.44x | -0.77x | 60.56x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.00x | 8.74x | 16.41x | 2.52x | 12.01x |
| PEG RatioP/E ÷ EPS growth rate | 1.02x | 0.37x | — | — | — |
| EV / EBITDAEnterprise value multiple | 9.46x | 6.59x | 8.91x | 5.76x | 30.40x |
| Price / SalesMarket cap ÷ Revenue | 1.37x | 1.96x | 1.61x | 0.07x | 1.56x |
| Price / BookPrice ÷ Book value/share | 0.97x | 1.56x | 1.56x | 1.31x | 2.37x |
| Price / FCFMarket cap ÷ FCF | 8.75x | 8.22x | 8.91x | 1.82x | 8.49x |
Profitability & Efficiency
NICE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NICE delivers a 16.4% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-100 for TTEC. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to TTEC's 8.86x. On the Piotroski fundamental quality scale (0–9), VRNT scores 7/9 vs TTEC's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.6% | +16.4% | +7.3% | -99.6% | +3.9% |
| ROA (TTM)Return on assets | +2.8% | +11.8% | +5.2% | -14.2% | +2.0% |
| ROICReturn on invested capital | +5.3% | +13.2% | +11.3% | +6.2% | +6.1% |
| ROCEReturn on capital employed | +5.9% | +16.1% | +12.1% | +7.5% | +6.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.34x | 0.04x | 0.05x | 8.86x | 0.08x |
| Net DebtTotal debt minus cash | $233M | -$216M | -$18M | $917M | -$116M |
| Cash & Equiv.Liquid assets | $216M | $379M | $25M | $83M | $163M |
| Total DebtShort + long-term debt | $448M | $164M | $7M | $1.0B | $47M |
| Interest CoverageEBIT ÷ Interest expense | 8.24x | — | — | -4.22x | — |
Total Returns (Dividends Reinvested)
SPOK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPOK five years ago would be worth $16,194 today (with dividends reinvested), compared to $556 for TTEC. Over the past 12 months, VRNT leads with a +17.9% total return vs NICE's -40.4%. The 3-year compound annual growth rate (CAGR) favors SPOK at 4.3% vs TTEC's -51.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | — | -14.6% | -14.3% | -14.3% | -25.5% |
| 1-Year ReturnPast 12 months | +17.9% | -40.4% | -26.7% | -21.9% | -29.6% |
| 3-Year ReturnCumulative with dividends | -39.3% | -49.3% | +13.4% | -88.9% | -52.0% |
| 5-Year ReturnCumulative with dividends | -56.1% | -59.1% | +61.9% | -94.4% | -69.0% |
| 10-Year ReturnCumulative with dividends | -37.1% | +50.7% | +13.3% | -61.8% | -69.0% |
| CAGR (3Y)Annualised 3-year return | -15.3% | -20.2% | +4.3% | -51.9% | -21.7% |
Risk & Volatility
Evenly matched — VRNT and SPOK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SPOK is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than TTEC's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRNT currently trades 89.8% from its 52-week high vs NICE's 53.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.26x | 0.72x | 0.42x | 1.84x | 0.82x |
| 52-Week HighHighest price in past year | $22.84 | $180.61 | $19.31 | $5.60 | $9.40 |
| 52-Week LowLowest price in past year | $16.23 | $94.89 | $9.96 | $1.98 | $4.71 |
| % of 52W HighCurrent price vs 52-week peak | +89.8% | +53.0% | +56.1% | +54.6% | +58.0% |
| RSI (14)Momentum oscillator 0–100 | 68.4 | 40.9 | 36.7 | 52.9 | 46.1 |
| Avg Volume (50D)Average daily shares traded | 0 | 631K | 185K | 662K | 3.4M |
Analyst Outlook
SPOK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRNT as "Hold", NICE as "Buy", SPOK as "Hold", TTEC as "Hold", CXM as "Hold". Consensus price targets imply 1016.7% upside for TTEC (target: $34) vs 30.8% for CXM (target: $7). For income investors, SPOK offers the higher dividend yield at 11.95% vs VRNT's 1.56%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $32.57 | $150.88 | $15.00 | $34.17 | $7.13 |
| # AnalystsCovering analysts | 16 | 23 | 1 | 14 | 17 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | — | +11.9% | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | 5 | 0 | 1 |
| Dividend / ShareAnnual DPS | $0.32 | — | $1.29 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.8% | +8.5% | +1.3% | 0.0% | +0.4% |
NICE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SPOK leads in 2 (Total Returns, Analyst Outlook). 1 tied.
VRNT vs NICE vs SPOK vs TTEC vs CXM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VRNT or NICE or SPOK or TTEC or CXM a better buy right now?
For growth investors, NICE Ltd.
(NICE) is the stronger pick with 7. 7% revenue growth year-over-year, versus -3. 2% for TTEC Holdings, Inc. (TTEC). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate NICE Ltd. (NICE) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRNT or NICE or SPOK or TTEC or CXM?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus Sprinklr, Inc. at 60. 6x. On forward P/E, TTEC Holdings, Inc. is actually cheaper at 2. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 33x versus Verint Systems Inc. 's 0. 36x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VRNT or NICE or SPOK or TTEC or CXM?
Over the past 5 years, Spok Holdings, Inc.
(SPOK) delivered a total return of +61. 9%, compared to -94. 4% for TTEC Holdings, Inc. (TTEC). Over 10 years, the gap is even starker: NICE returned +50. 7% versus CXM's -69. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRNT or NICE or SPOK or TTEC or CXM?
By beta (market sensitivity over 5 years), Spok Holdings, Inc.
(SPOK) is the lower-risk stock at 0. 42β versus TTEC Holdings, Inc. 's 1. 84β — meaning TTEC is approximately 339% more volatile than SPOK relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 9% for TTEC Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRNT or NICE or SPOK or TTEC or CXM?
By revenue growth (latest reported year), NICE Ltd.
(NICE) is pulling ahead at 7. 7% versus -3. 2% for TTEC Holdings, Inc. (TTEC). On earnings-per-share growth, the picture is similar: Verint Systems Inc. grew EPS 271. 4% year-over-year, compared to -79. 5% for Sprinklr, Inc.. Over a 3-year CAGR, CXM leads at 11. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRNT or NICE or SPOK or TTEC or CXM?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus -9. 0% for TTEC Holdings, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus 4. 5% for TTEC. At the gross margin level — before operating expenses — SPOK leads at 78. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRNT or NICE or SPOK or TTEC or CXM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 33x versus Verint Systems Inc. 's 0. 36x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, TTEC Holdings, Inc. (TTEC) trades at 2. 5x forward P/E versus 16. 4x for Spok Holdings, Inc. — 13. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TTEC: 1016. 7% to $34. 17.
08Which pays a better dividend — VRNT or NICE or SPOK or TTEC or CXM?
In this comparison, SPOK (11.
9% yield), VRNT (1. 6% yield) pay a dividend. NICE, TTEC, CXM do not pay a meaningful dividend and should not be held primarily for income.
09Is VRNT or NICE or SPOK or TTEC or CXM better for a retirement portfolio?
For long-horizon retirement investors, Spok Holdings, Inc.
(SPOK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 11. 9% yield). TTEC Holdings, Inc. (TTEC) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPOK: +13. 3%, TTEC: -61. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRNT and NICE and SPOK and TTEC and CXM?
These companies operate in different sectors (VRNT (Technology) and NICE (Technology) and SPOK (Healthcare) and TTEC (Technology) and CXM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VRNT is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; SPOK is a small-cap deep-value stock; TTEC is a small-cap quality compounder stock; CXM is a small-cap quality compounder stock. VRNT, SPOK pay a dividend while NICE, TTEC, CXM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.